In freshly isolated B cells, BTLA and CTLA-4 mRNA expression levels were substantially higher in CLL patients than in healthy controls (HC) (p = 0.0067 and p = 0.000005, respectively; Figure 1). This evidence concerns the gene BTLA and B-cell chronic lymphocytic leukemia.